FDA fast-tracks Lymphoseek for HNC detection
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Navidea Biopharmaceuticals’ Lymphoseek (technetium-99m tilmanocept) injection for sentinel lymph node detection in head
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Navidea Biopharmaceuticals’ Lymphoseek (technetium-99m tilmanocept) injection for sentinel lymph node detection in head
LED Dental and Burkhart Dental Supply have entered into a nonexclusive partnership for the distribution of LED’s VELscope Vx and product line within the U.S.
There is insufficient evidence to recommend for or against oral cancer screening in asymptomatic adults age 18 years or older by primary care physicians, according
Journeyworks Publishing, creator of tobacco prevention brochures, has added a new wristband for kids to its smokeless tobacco prevention efforts. The “Spit It Out” wristband
Agilent Technologies will collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia, on oral cancer research. Their goal is to increase
Bitter melon extract may have therapeutic potential to treat head and neck squamous cell carcinoma (HNSCC), according to a new study in PLOS One (October
Atlantic Health’s Carol G. Simon Cancer Center has received a $3 million donation from a cattle dealer from Randolph, NJ, to establish the Leonard B.
Canadian researchers have identified a protein that can help predict whether a patient will develop oral cancer, according to a recent study in the International
The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is growing, and the human papillomavirus (HPV) is linked to an increasing number of such cases. Studies
Patients with oropharyngeal squamous cell carcinoma (OPSCC) and human papillomavirus (HPV) are largely unaware of a possible link between the two conditions, according to a
Some 35% to 60% of all patients with head and neck cancers (HNC) are malnourished when they are diagnosed, according to a new study in
European researchers have identified unique DNA markings that may predict the risk of developing head and neck cancer, according to a study in the journal